This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Assia Chemical Industries Ltd., Watson Laboratories Inc.. Active years: 2021-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2023
Title: **Mane Ganesh Shivaji: Innovator in Pharmaceutical Processes**
Introduction
Mane Ganesh Shivaji, an accomplished inventor based in Thane, India, has contributed significantly to the field of pharmaceuticals with his groundbreaking innovations. With a total of 2 patents to his name, his work primarily focuses on the preparation of advanced pharmaceutical formulations.
Latest Patents
Shivaji's latest patents revolve around the process for the preparation of Remimazolam and solid-state forms of Remimazolam salts. The disclosures detail novel processes for creating short-acting benzodiazepines and include the preparation of intermediates for Methyl 3-[(4S)-8-bromo-1-methyl-6-(pyridin-2-yl)-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl]propanoate, commonly known as Remimazolam. This innovative work encompasses solid-state forms of Remimazolam salts, methods for their preparation, and pharmaceutical formulations, highlighting promising applications in medicine.
Career Highlights
Throughout his career, Mane Ganesh Shivaji has been associated with reputable companies, including Assia Chemical Industries Ltd. and Watson Laboratories Inc. His experiences in these organizations have significantly shaped his expertise in pharmaceutical innovations and patent development.
Collaborations
Shivaji has collaborated with notable professionals in his field, including Dolitzky Ben-Zion and Mendelovici Marioara. These collaborations have likely fostered a rich environment for innovation and professional growth, further enhancing his contributions to pharmaceutical sciences.
Conclusion
Mane Ganesh Shivaji stands out as a prominent figure in the realm of pharmaceutical inventions, especially through his work with Remimazolam. His patents reflect a commitment to advancing medical science and improving patient care through innovative drug formulations. As he continues to develop new processes and formulations, Shivaji's impact on the pharmaceutical industry is bound to grow.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile